COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence

Letter Allergy

COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

Enrico Heffler et al.

ALLERGY (2021)

添加到收藏夹

Letter Allergy

Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control and Prevention

Hyo-Geun Choi et al.

ALLERGY (2021)

添加到收藏夹

Article Critical Care Medicine

Asthma in Adult Patients with COVID-19 Prevalence and Risk of Severe Disease

Paul D. Terry et al.

Summary: The study found no clear evidence of an increased risk of COVID-19 diagnosis, hospitalization, severity, or mortality due to asthma based on analysis of 150 studies worldwide.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Allergy

Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness

Denisa Ferastraoaru et al.

Summary: In asthmatics with COVID-19, pre-existing eosinophilia is associated with lower risk of hospital admission, while development of eosinophilia during hospitalization is linked to decreased mortality. Eosinophil levels before admission influence trends during hospitalization, with a Th2-asthma phenotype potentially predicting reduced COVID-19 morbidity and mortality.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Critical Care Medicine

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloe Bloom et al.

Summary: This study analyzed data from patients admitted to hospital with COVID-19 in England, Scotland, and Wales from January 17 to August 3, 2020. The findings showed that patients with asthma were more likely to receive critical care, while patients with chronic pulmonary disease were less likely. In older patients, inhaled corticosteroid use reduced mortality rates in asthma patients but not in those with chronic pulmonary disease.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Allergy

COVID-19 Susceptibility in Bronchial Asthma

Ilan Green et al.

Summary: The study on the prevalence and related factors of asthma in COVID-19 patients shows that patients with asthma have a lower susceptibility to COVID-19, and there is no significant correlation between asthma patients and the positivity rate of COVID-19.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Respiratory System

The impact of COVID-19 on patients with asthma

Jose Luis Izquierdo et al.

Summary: The study analyzed clinical data of 71,182 asthma patients and found that those with COVID-19 were older, predominantly female, and had higher prevalence of comorbidities. The use of inhaled corticosteroids and biologics in asthma patients may have a protective effect against severe COVID-19 infection.

EUROPEAN RESPIRATORY JOURNAL (2021)

添加到收藏夹

Article Respiratory System

Effect of asthma and asthma medication on the prognosis of patients with COVID-19

Yong Jun Choi et al.

Summary: The study found that asthma patients with COVID-19 had a significantly higher mortality rate than other patients, but asthma was not an independent risk factor for the clinical outcomes of COVID-19. Furthermore, asthma medication use and asthma severity did not affect the clinical outcomes of COVID-19.

EUROPEAN RESPIRATORY JOURNAL (2021)

添加到收藏夹

Article Allergy